Endocrinology, Diabetes & Metabolism Doctors in Weston, FL Accepting Medicare

6 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 6

Vineeth Mohan, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000    Fax: 954-659-6039

Alexandra Mikhael, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000

Tessey Chinna Jose, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-470-1629

Jose M Cabral, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000    Fax: 954-659-5272

Malgorzata Beckman, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5271    Fax: 954-659-5272

Dr. Karla M Arce, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5271

News Archive

Forest Laboratories Holdings and Almirall to develop, market and distribute LAS100977 in the US

Forest Laboratories Holdings, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. and Almirall, S.A. (ALM.MC) today announced that they have entered an agreement to develop, market and distribute LAS100977 in the United States.

Health insurance prices, restrictions now on federal consumer website

Kaiser Health News staff writer Jessica Marcy talked with Todd Park, the chief technology officer of the Department of Health and Human Services, and Karen Pollitz, who heads the consumer support division at HHS Office of Consumer Information and Insurance Oversight, about the detailed health plan cost and benefits information unveiled today on Healthcare.gov.

Avexxin concludes second phase I/IIA study in patients suffering from mild-to-moderate psoriasis

Avexxin AS, a therapeutic company focusing on the discovery and development of novel small molecule therapeutics for patients suffering from chronic inflammatory conditions, announces the completion of a second phase I/IIa study showing Proof-of-Concept in man.

Alexion first quarter non-GAAP net income increases to $56.3 million

Alexion Pharmaceuticals, Inc. today announced financial results for the three months ended March 31, 2011. Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $166.1 million, reflecting steady additions of new patients, compared to $117.6 million for the same period in 2010.

Smokers who seem healthy have damaged airway cells similar to cells found in aggressive lung cancer

​Smokers who've received a clean bill of health from their doctor may believe cigarettes haven't harmed their lungs. However, researchers at Weill Cornell Medical College have found that even smokers who seem healthy have damaged airway cells, with characteristics similar to cells found in aggressive lung cancer.

Read more Medical News

› Verified 8 days ago